🔎 Trials Near Me

Home › Paraganglioma › California

Paraganglioma clinical trials in California

3 studies for Paraganglioma are looking for participants at sites in California.

Cities in California

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  • Cedars-Sinai Medical Center ( Site 0110), Los Angeles
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT04924075

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

  • UCLA, Los Angeles
  • Stanford, Palo Alto
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT07282587

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

  • City of Hope, Duarte
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
  • Stanford Cancer Institute, Stanford
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.